FDA Approves Synjardy for Type 2 Diabetes

Boehringer Ingelheim and Eli Lilly announced in a news release that the US Food and Drug Administration has granted approval for a new, SGLT2 inhibitor/metformin combination drug called Synjardy for people with type 2 diabetes.

Synjardy combines the sodium glucose cotransporter 2 (SGLT2) inhibitor empagliflozin with metformin hydrochloride.

It becomes the third approved drug in the United States that contains empagliflozin -- the others being Glyxambi and Jardiance -- and it is also the third SGLT2 inhibitor/metformin combination to arrive on the US market, preceded by Xigduo XR and Invokamet.

Synjardy was approved for the European market in May 2015.

The FDA has approved Synjardy as an adjunct or addition to diet and exercise in efforts to improve glycemic control in adults with type 2 diabetes who are not adequately controlled with either empagliflozin or metformin as therapies unto themselves (monotherapies), or in patients already being treated with either empagliflozin and metformin.

Synjardy is not indicated for the treatment of type 1 diabetes or diabetic ketoacidosis.

The FDA will include on Synjardy a boxed warning, as it includes with all products containing metformin, which warns about the risk of lactic acidosis.

Source: Lilly

Get a Free Diabetes Meal Plan

Get a free 7-Day Diabetes Meal Plan from Constance Brown-Riggs who is a Registered Dietitian-Certified Diabetes Educator and who is also a national spokesperson for the American Dietetic Association.

Just enter in your email below to download your free Diabetes Meal Plan.

By clicking Submit, you agree to send your info to BattleDiabetes.com who, in addition to 3rd party partners, may contact you with updates, products and information and we agree to use it according to our privacy policy and terms and conditions.

More Articles

More Articles

Scientists have discovered that a single gene forms a common link between type 2 diabetes and...

Natural supplements like cinnamon extract and apple cider vinegar could hold the key to lowering blood sugar levels, according to a recent...

Natural supplements like cinnamon extract and apple cider vinegar could hold the key to lowering blood sugar levels, according to a recent...

Could a person's risk for type 2 diabetes be written in their genes?

According to a study recently published in ...

Women who frequently shift around their sleeping hours could have worse metabolic health outcomes than their peers who stick with a...

The presence of the hormone leptin may hinder prenatal development, which could explain the origin of type 2 diabetes, according to...

An analysis of fossilized Native American feces shows that our ancestors ate up to sixteen times the fiber that we do today, but our...

Managing diabetes is hugely challenging for people of any age, but a new study suggests that young people may suffer all the more....

Disruptions to the gut’s ecosystem could be a future symptom facing young children who take antibiotics, which makes them more susceptible...

Breastfeeding a newborn holds many benefits for mommy and baby; it reduces the baby's risk for colds and viruses, it helps his bones (and yours)...

Fans of the Dexcom G5 Mobile have something to smile about.

At yesterday's hearing with the U.S. Food and Drug...

If you start your day with a cup of tea and end it with a glass of red wine, your blood sugar may thank you.

At least that...

As medical experts continue to debate whether or not "healthy obesity" can even exist, one new study suggests that risk for heart disease...

For years, type 1 diabetics have been anxiously waiting for that medical marvel that can stop the constant injections: the artificial...

“Low-fat” has been the battle cry of the health-conscious for over ‌‌‌‌‌‌‌‌‌‌‌...